• Acne
  • Actinic Keratosis
  • Aesthetics
  • Alopecia
  • Atopic Dermatitis
  • Buy-and-Bill
  • COVID-19
  • Case-Based Roundtable
  • Chronic Hand Eczema
  • Chronic Spontaneous Urticaria
  • Drug Watch
  • Eczema
  • General Dermatology
  • Hidradenitis Suppurativa
  • Melasma
  • NP and PA
  • Pediatric Dermatology
  • Pigmentary Disorders
  • Practice Management
  • Precision Medicine and Biologics
  • Prurigo Nodularis
  • Psoriasis
  • Psoriatic Arthritis
  • Rare Disease
  • Rosacea
  • Skin Cancer
  • Vitiligo
  • Wound Care

Article

Valeant to acquire Toronto maker of derm products

Aliso Viejo, Calif. - Valeant Pharmaceuticals, based here, will acquire Vital Science Corp., a Toronto-based manufacturer of over-the-counter dermatology products, news source Socaltech.com reports.

Aliso Viejo, Calif. - Valeant Pharmaceuticals, based here, will acquire Vital Science Corp., a Toronto-based manufacturer of over-the-counter dermatology products, news source Socaltech.com reports.

Valeant officials say the deal is worth about $10.5 million in Canadian dollars. They expect closing to occur in the second quarter, according to the report.

Valeant acquired two other dermatology firms, both in Brazil, earlier this year.

Newsletter

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

© 2025 MJH Life Sciences

All rights reserved.